House of Lords Hansard Index for Volume 647—continued

Previous SectionIndexHome Page


A   Ag   An   Ap   At   Ay   B   Be   Bi   Bo   Bu   By   C   Ce   Cl   Co   Cr   D   Dh   Do   E   Em   Ev   F   Fa   Fe   Fl   G   Gh   Gr   Gu   H   He   Hu   Hy   I   Is   J   K   L   Le   Li   Lo   Ly   M   Mc   Ma   Mb   Mo   Mu   N   Ni   Nu   O   Op   P   Ph   Pn   Pu   Q   R   Rh   Ru   S   St   Se   Si   Sn   Su   T   Ti   Tu   U   V   W   We   Wi   Wo   X   Y   Z                                                                                                                                                                                                           

Hughes of Woodside, Lord:

    Angola, [642] (11.12.02) 312-14.

    Barnett Formula, [643] (27.1.03) 914.

    CITB and ECITB, Quinquennial Review, Question, [645] (11.3.03) WA180.

    Cyprus, Question, [645] (3.3.03) WA86.

    Death of Detective Constable Stephen Oake, Inquiry, Question, [643] (16.1.03) WA64.

    European Union, Forthcoming Council Business and Major Events, Question, [641] (3.12.02) WA101.

    Extractive Industries Transparency Initiative, [647] (29.4.03) 570.

    Foot and Mouth Disease Contingency Plan, Question, [646] (1.4.03) WA117.

    House of Lords:

      Reform, [643] (21.1.03) 630-2.

      Voting Procedure, [644] (13.2.03) 816.

    Iraq, Question, [641] (3.12.02) WA92.

    Mbeki, President, Chequers Meeting, [644] (19.2.03) 1130-1.

    Public Libraries, Question, [644] (11.2.03) WA114.

    Scottish Parliament, [642] (18.12.02) 702-3.

    Updated Drug Strategy, Question, [641] (3.12.02) WA90.

    Zimbabwe, [642] (10.12.02) 106; (7.1.03) 891; [645] (5.3.03) 882-4; [647] (7.4.03) 9.

Hull:

    Cautions and Convictions, Question, [646] (4.4.03) WA156-7.

    Ethnic and Religious Breakdown, Question, [646] (31.3.03) WA93-6.

    GCSE Pass Levels, Question, [646] (18.3.03) WA22.

    Human Rights, Question, [647] (28.4.03) WA86.

    Level of Poverty, Question, [646] (18.3.03) WA21-2.

    Unemployment, Question, [645] (13.3.03) WA190-1.

Human Cloning:

    Question, [646] (17.3.03) WA12.

Human Diploid Cells:

    Question, [646] (4.4.03) WA153.

Human Eggs:

    Question, [642] (18.12.02) WA114.

Human Embryos in Research:

    Question, [645] (25.2.03) WA25.

Human Fertilisation and Embryology Authority:

    Annual Report and Accounts, Question, [642] (12.12.02) WA59.

    Licences, Question, [642] (19.12.02) WA154-6.

    Question, [641] (4.12.02) WA116.

Human Reproduction:

    Sex Selection Consultation, Question, [641] (2.12.02) WA82-3.

Human Rights:

    Conventions, Question, [646] (17.3.03) WA3-4.

    Question, [646] (27.3.03) 950-2.

Human Rights Act 1998:

    Guidance, Question, [643] (29.1.03) WA154.

    Local Authority Policies and Travelling People, Question, [647] (29.4.03) WA91.

Human Rights Committee:

    Motion for Approval (Lord Brabazon of Tara), [641] (2.12.02) 969-70.

Human Rights Obligations:

    Question, [647] (7.4.03) WA1.

Hungary:

    Question, [641] (27.11.02) WA46.

Hunt of Chesterton, Lord:

    Buildings, Energy Efficiency, Question, [644] (20.2.03) 1266.

    Debate on the Address, [641] (20.11.02) 448-52.

    Design in Public Services, [643] (29.1.03) 1143-5.

    Disaster Planning, [641] (2.12.02) 966.

    Emergency Planning, [641] (4.12.02) 1192-5.

    Engineers, [641] (4.12.02) 1212-15.

    Higher Education Applications, [644] (20.2.03) 1275.

    Microchips, [645] (14.3.03) 1573-6.

    Missile Defence, [643] (15.1.03) 266.

    Sustainable Development, Question, [641] (21.11.02) 511.

    Water Supply, Sanitation and Hygiene, Question, [641] (26.11.02) WA29.

Hunt of Kings Heath, Lord:

    Abortions:

      Girls Aged 12 and Under, [642] (16.12.02) WA74.

    Abortion Act 1967, Section 1(1) (d), [641] (2.12.02) WA83.

    Accidental Injury, [643] (13.1.03) WA20-1.

    Acrylamide, [641] (2.12.02) WA78-9.

    Adoption, [641] (2.12.02) WA77.

    Agency Workers Directive, [641] (5.12.02) WA124.

    Age-related Macular Degeneration, [644] (10.2.03) WA92.

    Antenatal Care, [645] (27.2.03) WA58-9.

    Anthrax Vaccine, [643] (20.1.03) WA79.

    Assisted Reproductive Technologies, [641] (4.12.02) WA117.

    Asylum Seekers:

      Health Screening, [642] (7.1.03) WA193.

      Tuberculosis Screening, [642] (16.12.02) WA74, WA75.

    Attention Deficit Hyperactivity Disorder:

      Consultants and School Nurses, [641] (2.12.02) WA78.

    Blood Donors, vCJD, [642] (19.12.02) WA156.

    Branded Medicines, [642] (19.12.02) WA159.

    Breast Screening, [642] (7.1.03) 886-7.

    Cancer Services, [642] (9.12.02) WA14.

    Cannabis:

    Care Trusts, [641] (2.12.02) WA79.

    Chemical, Biological, Radiological and Nuclear Incidents, NHS Guidance in the North West, [644] (10.2.03) WA89-90.

    Children, [644] (12.2.03) 745-50.

    Clinical and Managerial Practice, NICE Guidance, [643] (29.1.03) WA172.

    Community Care (Delayed Discharges etc.) Bill:

      Regulatory Impact Assessment, [644] (10.2.03) WA94.

    Community Health Councils, Abolition, [644] (3.2.03) 10, 11-12, 13.

    Coronary Heart Disease, Drug Eluting Stents, [645] (5.3.03) WA118.

    Culture Media Production, [644] (10.2.03) WA94.

    Deafblind Children, [645] (13.3.03) WA202.

    Deafblind People, Social Care, [646] (17.3.03) WA10-11.

    Deafblind Support, [645] (13.3.03) WA202.

    Debate on the Address, [641] (19.11.02) 356-64.

    Department of Health:

      External Consultants, [642] (11.12.02) WA44.

      Private Sector Consultants, [641] (26.11.02) WA36.

      QWAs, [646] (17.3.03) WA12.

    Department of Health and Food Standards Agency, Supplementary Estimates, [645] (28.2.03) WA69-72.

    Diabetes, [641] (2.12.02) WA81-2.

    Diabetes National Service Framework Delivery Strategy, [642] (9.1.03) WA228-9.

    Digital Hearing Aids, [644] (13.2.03) 812-14.

    Disabled Children:

      Local Authority and NHS Support, [641] (21.11.02) WA10-11.

    Doctors, European Working Time Directive, [645] (4.3.03) 699, 700, 701, 702.

    Donor-conceived People, Access to Information, [643] (28.1.03) WA152.

    Drug and Alcohol Treatment Centres, Funding, [645] (26.2.03) WA35-6.

    Embryo Research, [643] (13.1.03) WA19-20.

    Employment, Social Policy, Health and Consumer Affairs Council, [643] (30.1.03) WA176-8.

    Epilepsy, [645] (6.3.03) 957-9.

    Fertility Clinics, [643] (16.1.03) WA60.

    Fluoridation of Water, [642] (11.12.02) WA44-5, WA46; (16.12.02) WA75.

    Foetal Alcohol Syndrome, [645] (27.2.03) WA59.

    Food Labelling, [642] (8.1.03) 1096-100.

    Food Standards Agency:

      Annual Report and Accounts 2001-02, [645] (26.2.03) WA38.

    Food Supplements, Nutrients, [646] (17.3.03) WA13.

    Foot and Mouth, Research into Emotional, Social and Mental Health Consequences, [641] (3.12.02) WA100.

    Free Personal Care for the Elderly, [642] (10.12.02) 99, 100-1.

    Free Prescriptions and Tax Credits, [642] (9.1.03) WA229-30.

    General Practitioners:

      Elderly and Disabled Patients, [643] (27.1.03) WA132.

      Prescribing, [642] (18.12.02) WA118-19.

    Generic Medicines, Maximum Price Scheme, [642] (12.12.02) WA59.

    Genetically Modified Cotton Crops, [645] (13.3.03) WA199.

    Glucose Meters, [645] (6.3.03) WA128.

    Greater Manchester Brain Injury Vocational Centre, [643] (14.1.03) WA33.

    Haemophilia:

      [643] (16.1.03) WA59; [646] (17.3.03) WA10.

      Patients, CMO's Report on Clinical Negligence Claims, [644] (4.2.03) WA23.

      Recombinant Clotting Products, [644] (12.2.03) WA128.

    Haemophiliacs:

      vCJD Implicated Products, [643] (22.1.03) WA100.

      With Hepatitis C, Correspondence, [644] (3.2.03) WA13.

    Health Professions Council, [644] (10.2.03) WA85, WA86.

    Health Visitors, [642] (19.12.02) WA157.

    Health (Wales) Bill, 2R, [644] (6.2.03) 346-51; Committee, [645] (26.2.03) GC2-3, GC4, GC6-8, GC10-11, GC13-14, GC15, GC16-17; Report, [646] (17.3.03) 66-8.

    Healthcare Workers, Smallpox, [641] (2.12.02) WA84.

    Healthy Eating among Young Adults, [645] (26.2.03) WA36.

    Hearing Aid Services, [641] (2.12.02) WA80, WA81.

    Hepatitis B, Transfusion Transmitted Infection, [641] (5.12.02) WA123.

    Hospices, [642] (9.12.02) WA14; (7.1.03) WA196.

    Hospital Admission, Declaration of Religious Affiliation, [642] (8.1.03) WA215.

    Hospital Consultants under Suspension, [642] (9.12.02) WA14.

    Hospital Discharges, [644] (17.2.03) WA156.

    Hospital Infections, [644] (17.2.03) WA155-6.

    Hospital Readmissions, [645] (24.2.03) WA7.

    Hospitals, Emergency Readmissions, [643] (30.1.03) 1277-80.

    Human Cloning, [646] (17.3.03) WA12.

    Human Eggs, [642] (18.12.02) WA114.

    Human Embryos in Research, [645] (25.2.03) WA25.

    Human Fertilisation and Embryology Authority:

      Annual Report and Accounts, [642] (12.12.02) WA59.

    Human Reproduction, Sex Selection Consultation, [641] (2.12.02) WA82-3.

    Infectious Diseases, Welsh Strategy, [643] (20.1.03) WA78.

    Injury Prevention, [643] (22.1.03) WA100.

    Isle of Wight, Emergency Surgery Facilities, [644] (19.2.03) 1132, 1133, 1134, 1135.

    IVF Embryos, Fertility Treatment, [643] (29.1.03) WA169-70.

    King Edward VII Hospital, Midhurst, [643] (28.1.03) WA151; [644] (11.2.03) 556, 557, 558.

    Lactase Tablets, [645] (25.2.03) WA25.

    Legionella Outbreak in Barrow-in-Furness, PHLS Support, [642] (7.1.03) WA193-4.

    Local Authority Children's Homes, [642] (7.1.03) WA194-5.

    Local Council Children's Homes, Staff Qualifications, [641] (21.11.02) WA13.

    Managed Pathology Networks, [645] (13.3.03) WA198.

    Maternity Services, [643] (15.1.03) 293-300.

    Mattresses, Medical Devices Regulations 2002, [645] (5.3.03) WA117.

    Medical Act 1983 (Amendment) Order 2002, Motion, [641] (3.12.02) 1098-101, 1107-12.

    Medical Qualifications, [645] (25.2.03) WA24.

    Medical Reservists, NHS Responsibilities, [644] (5.2.03) 197, 198.

    Mental Health, Black and Minority Ethnic Groups, [642] (7.1.03) WA196.

    Mental Health Services, [646] (17.3.03) 5, 6.

    Misuse, Alcohol, [642] (19.12.02) WA154.

    Modernising Medical Careers, [645] (25.2.03) WA25-6.

    Multiple Sclerosis:

      Beta Interferon, [645] (5.3.03) WA117.

      Treatment, North West London, [643] (27.1.03) WA132.

    National Alcohol Harm Reduction Strategy, [644] (10.2.03) WA95.

    National Committees, Manufacturer Representatives, [641] (2.12.02) WA78.

    National Health Service:

      Beds, [643] (21.1.03) 561-3.

      Cancelled Operations, [642] (12.12.02) 380-1, 382.

      Capital Allocations, [642] (8.1.03) WA217.

      Clinical Negligence Expenditure, [644] (10.2.03) WA93.

      Consultants, [643] (23.1.03) WA123-4.

      Continuing Care, Guidance, [646] (17.3.03) 1-3.

      Cost of Temporary Workers, [641] (3.12.02) WA101.

      Delayed Discharge and Emergency Re-admission, [641] (2.12.02) WA77; [642] (9.1.03) WA228.

      Delayed Discharges, [642] (9.12.02) WA12.

      Early Retirement Provision, [641] (2.12.02) WA82.

      Financial Flows System and Delayed Discharges, [644] (4.2.03) WA24.

      Franchising Register of Expertise, [642] (19.12.02) WA159-60.

      General and Acute In-patient Activity, [641] (2.12.02) WA79.

      In Wales, VAT, [646] (17.3.03) WA10.

      Independent Reconfiguration Panel, [642] (16.12.02) WA72-3; [644] (10.2.03) WA84, WA85.

      IT Projects, [642] (11.12.02) WA43-4.

      Laboratories:

Accreditation, [645] (13.3.03) WA199.

Bulk Procurement, [645] (27.2.03) WA58.

      Leaving Rates, [645] (10.3.03) WA158.

      Management Costs, [645] (10.3.03) WA159.

      Managers, Early Retirements, [641] (3.12.02) WA100-1.

      Mattresses and Fire Regulations, [645] (4.3.03) WA102.

      Minority Ethnic Nurses, [645] (10.3.03) WA158.

      Mixed-Sex Wards, [643] (13.1.03) 9, 10, 11.

      Negligence Claims, Haemophilia Society Proposal, [643] (22.1.03) WA101.

      Patient Environment, [643] (14.1.03) WA42.

      Professional Staff Exchanges, [642] (19.12.02) 779, 780-2.

      Professionals, [642] (9.12.02) WA13; (11.12.02) WA40-1; [645] (3.3.03) WA90.

      Provision of Digital Hearing Aids, Lancashire, [642] (19.12.02) WA150.

      Quarterly Review, [646] (17.3.03) WA13-14.

      Research and Development Budget, [642] (7.1.03) WA195.

      Resources, Statement, [642] (11.12.02) 265-9, 273-7.

      Revenue Resource Allocation, [643] (20.1.03) WA78-9.

      Staffing, [642] (17.12.02) 528-9, 530; [643] (14.1.03) WA32.

      Trusts:

Annual Accounts, [644] (10.2.03) WA94.

Clinical Governance, [642] (16.12.02) WA72.

Deficits, [643] (29.1.03) WA170.

Financial Arrangements, [645] (11.3.03) WA179-80.

Retained Deficits, [642] (19.12.02) WA157-8; [643] (27.1.03) WA133, WA134; [644] (10.2.03) WA87-8; [645] (26.2.03) WA34-5.

Standards, [645] (5.3.03) WA115.

      Use of Independent Sector, [645] (24.2.03) WA7.

      Use of International Healthcare Providers, [645] (26.2.03) WA34.

      Vital Connection, [645] (10.3.03) WA158-9.

      Work Permits, [641] (27.11.02) 739, 740-1.

      Workforce, [642] (11.12.02) WA43; [645] (10.3.03) WA157-8.

    National Institute for Clinical Excellence, [644] (3.2.03) WA13.

    National Service Framework for Children, [644] (11.2.03) 560-2, 563.

    North Staffordshire NHS Trust, Report of Review of Research Framework, [646] (17.3.03) WA14.

    Nursing and Midwifery Council, [645] (26.2.03) WA37.

    Nursing Care Homes, [644] (17.2.03) WA157.

    Nutritional Information, Catering Establishments, [641] (21.11.02) WA12.

    Nutritional Labelling, [641] (25.11.02) 555, 556, 557.

    Obesity, [644] (10.2.03) WA92-3.

    Osteoporosis, [642] (10.12.02) 101, 102-3.

    Osteoporotic Surgery, [641] (2.12.02) WA82.

    Ovarian Hyperstimulation, [645] (5.3.03) WA116.

    Overweight and Obesity, [644] (13.2.03) WA141-2.

    P C and S v The United Kingdom, [645] (5.3.03) WA117.

    Paediatric Continence, [645] (26.2.03) WA38.

    Parkinson's Disease Research, [642] (16.12.02) WA75.

    Pathology Modernisation Programme, [642] (19.12.02) WA150.

    Pathology Services, Strategic Review, [642] (19.12.02) WA153-4.

    Patients Contaminated with NHS Blood, [643] (29.1.03) WA170.

    Patients Forums, [642] (10.12.02) 106, 107-8.

    Perioperative Deaths Inquiry, [641] (26.11.02) WA35.

    Pharmaceutical Price Regulation Scheme, [642] (19.12.02) WA158-9.

    Pharmacy Services, [645] (10.3.03) WA157.

    Plasma Supplies, [642] (18.12.02) WA119-20.

    Pneumococcal Disease, [644] (13.2.03) WA142.

    Post-mortems, Retained Organs, [645] (25.2.03) 124, 125.

    Prescribing Budgets, [642] (11.12.02) WA41-2.

    Primary Care Trusts:

      Appointment of Non-executive Directors, [642] (7.1.03) 883-5.

      Specialised Services, [644] (13.2.03) WA142.

    Primary Healthcare, Rural One-Stop Centres, [641] (3.12.02) WA101.

    Private Care Homes, [641] (2.12.02) WA80.

    Private Residential Homes, Complaints Procedure, [642] (11.12.02) WA39-40.

    Private Sector Healthcare, [641] (28.11.02) 900-1, 902-3.

    Protection of Vulnerable Adults:

      List, [644] (17.2.03) WA156.

    Public Health Laboratories, [642] (19.12.02) WA151-3; [644] (13.2.03) WA140-1.

    Public Health Laboratory Service:

      Media Services, [645] (13.3.03) WA198.

    Reproductive Healthcare, [643] (13.1.03) WA20.

    Rheumatoid Arthritis, [643] (16.1.03) WA59-60.

    Road Traffic (NHS Charges) Act 1999, [645] (10.3.03) WA160.

    Safeguarding Children, [643] (14.1.03) WA31.

    School Nurses, [646] (17.3.03) WA9.

    Severely Disabled Children, [644] (3.2.03) WA14-16.

    Sex Selection, [643] (13.1.03) WA21.

    Sexually Transmitted Diseases, [643] (28.1.03) WA150; [644] (6.2.03) 361-3.

    Smoking in Pregnancy, [645] (26.2.03) WA36.

    Smoking in Public Places, [643] (21.1.03) 558-61.

    Smoking-related Diseases, [643] (20.1.03) WA79-80.

    Stem Cell Research:

      Select Committee Report, [641] (5.12.02) 1345-50.

    Strategic Health Authorities:

      [645] (24.2.03) 5-6, 7.

      Mutual Fund, [644] (10.2.03) WA84.

    Student Suicides, [643] (20.1.03) 433, 434-5.

    Terrorism, NHS Preparedness, [641] (20.11.02) 375-6, 377, 378.

    Thimerosal/Thiomersal, [642] (16.12.02) WA73-4; [643] (27.1.03) WA131.

    Thimerosal/Mercury-based Vaccines, [643] (22.1.03) WA101.

    Tobacco Industry, Representations, [645] (28.2.03) WA72.

    Transfusion-related Acute Lung Injury, [641] (4.12.02) WA115.

    vCJD, [643] (20.1.03) WA80.

    West Nile Fever Virus, Blood Transfusion Risk, [641] (5.12.02) WA124.

    World Health Organisation Director General, [642] (11.12.02) WA41.

Hunt of Wirral, Lord:

    Access to Justice Act 1999 (Solicitors' Practising Certificates) Order 2002, [642] (17.12.02) 612-13.

    Crime (International Co-operation) Bill [HL], 2R, [641] (2.12.02) 1009-12.

Hunting:

    Ban, Farmers' Use of Shotguns and Snares, Question, [644] (4.2.03) WA22.

    Questions, [642] (7.1.03) WA188; [643] (23.1.03) WA119.

    Welfare of Dogs and Horses, Question, [643] (28.1.03) WA148-9.

Hunting Bill:

    Background Research, Question, [642] (9.1.03) WA226-7.

    Effects on Shooting, Question, [645] (27.2.03) 421-4.

    Questions, [644] (13.2.03) WA139; [645] (25.2.03) WA15.

    Rio Declaration on Environment and Development, Question, [642] (9.1.03) WA227.

Hunting with Dogs:

    Statement (Lord Whitty), [641] (3.12.02) 1048-63.

Hurd of Westwell, Lord:

    Government Disputes, Resolution Procedures, Question, [644] (13.2.03) 810.

    Government Information and Communication Service, [647] (29.4.03) 575.

    Palestinian Reform, London Meeting, [643] (16.1.03) 349.

    Prison Population, Question, [641] (3.12.02) 1027-8.

Hussey of North Bradley, Lord:

    Communications Bill, Committee, [647] (29.4.03) 610.

    Debate on the Address, [641] (20.11.02) 397-400.

    Disabled People, [647] (30.4.03) 726.


Next Section

IndexHome Page